Literature DB >> 2450837

The T11(3) epitope of the CD2 molecule, sheep erythrocytes, and the alternative T-cell activation pathway.

H S Warren1, V McPhun, A Bezos, C R Parish.   

Abstract

In this study, results are presented showing that the T11(3) epitope of the CD2 molecule is expressed on unfractionated peripheral blood mononuclear cells, resting T cells and activated T cells. T11(3) is not therefore, an activation-specific CD2 epitope. Sheep erythrocytes (SRC) which present a cell-surface ligand for CD2 could not effectively replace anti-T11(2) in initiating proliferation of resting T cells, stimulated by anti-T11(3). SRC with either of these anti-CD2 monoclonal antibodies did activate resting T cells, but proliferation required the presence of added IL-2.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450837      PMCID: PMC1454524     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  11 in total

1.  T cell activation via CD2 [T, gp50]: the role of accessory cells in activating resting T cells via CD2.

Authors:  S Huet; H Wakasugi; G Sterkers; J Gilmour; T Tursz; L Boumsell; A Bernard
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

2.  Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand.

Authors:  T Hünig; G Tiefenthaler; K H Meyer zum Büschenfelde; S C Meuer
Journal:  Nature       Date:  1987 Mar 19-25       Impact factor: 49.962

3.  Functional consequences of sheep red blood cell rosetting for human T cells: gain of reactivity to mitogenic factors.

Authors:  E L Larsson; J Andersson; A Coutinho
Journal:  Eur J Immunol       Date:  1978-10       Impact factor: 5.532

4.  Anti-CD2 (sheep red blood cell receptor) monoclonal antibodies and T cell activation. I. Pairs of anti-T11.1 and T11.2 (CD2 subgroups) are strongly mitogenic for T cells in presence of 12-O-tetradecanoylphorbol 13-acetate.

Authors:  D Olive; M Ragueneau; C Cerdan; P Dubreuil; M Lopez; C Mawas
Journal:  Eur J Immunol       Date:  1986-09       Impact factor: 5.532

5.  Preparation and characterization of human bone marrow-derived macrophages.

Authors:  D A Hume; W Allan; J Golder; R W Stephens; W F Doe; H S Warren
Journal:  J Leukoc Biol       Date:  1985-10       Impact factor: 4.962

6.  Phytohaemagglutinin activation of T cells through the sheep red blood cell receptor.

Authors:  K O'Flynn; A M Krensky; P C Beverley; S J Burakoff; D C Linch
Journal:  Nature       Date:  1985 Feb 21-27       Impact factor: 49.962

7.  An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein.

Authors:  S C Meuer; R E Hussey; M Fabbi; D Fox; O Acuto; K A Fitzgerald; J C Hodgdon; J P Protentis; S F Schlossman; E L Reinherz
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

8.  T11TS, the cell surface molecule binding to the "erythrocyte receptor" of T lymphocytes: cellular distribution, purification to homogeneity and biochemical properties.

Authors:  T Hünig; R Mitnacht; G Tiefenthaler; C Köhler; M Miyasaka
Journal:  Eur J Immunol       Date:  1986-12       Impact factor: 5.532

9.  Heterogeneity in the activation requirements of T cells stimulated by phytohaemagglutinin.

Authors:  H S Warren; A Bezos
Journal:  Immunology       Date:  1987-06       Impact factor: 7.397

10.  The cell surface molecule recognized by the erythrocyte receptor of T lymphocytes. Identification and partial characterization using a monoclonal antibody.

Authors:  T Hünig
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

View more
  1 in total

1.  Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV-infected individuals.

Authors:  A Vyakarnam; P Matear; A Meager; G Kelly; B Stanley; I Weller; P Beverley
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.